SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,444,616 | -45.2% | 105,736 | -37.8% | 0.00% | -40.0% |
| Q2 2023 | $4,458,632 | -43.5% | 170,047 | -44.5% | 0.01% | -37.5% |
| Q1 2023 | $7,890,468 | +63.2% | 306,545 | +64.9% | 0.01% | +60.0% |
| Q4 2022 | $4,835,779 | +16.4% | 185,920 | +27.7% | 0.01% | 0.0% |
| Q3 2022 | $4,154,000 | -31.3% | 145,610 | -40.7% | 0.01% | -28.6% |
| Q2 2022 | $6,043,000 | +75.0% | 245,463 | +340.7% | 0.01% | +133.3% |
| Q4 2021 | $3,453,000 | -45.8% | 55,704 | -44.5% | 0.00% | -50.0% |
| Q3 2021 | $6,373,000 | -38.6% | 100,457 | -20.2% | 0.01% | -33.3% |
| Q2 2021 | $10,374,000 | -6.1% | 125,879 | -16.2% | 0.01% | -18.2% |
| Q1 2021 | $11,053,000 | +125.6% | 150,241 | +122.3% | 0.01% | +175.0% |
| Q4 2020 | $4,900,000 | – | 67,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |